Second hantavirus death in Tarija Department, Bolivia, linked to farming activities
Read original atvertexaisearch.cloud.google.com
Yacuiba, Tarija, BoliviaConfidence 95%2 affectedToday
The Departmental Health Service of Tarija, Bolivia, confirmed the second hantavirus-related death in 2026, following a first death in the same area, with both linked to agricultural activities. Nine suspected cases have been reported in the region.
Species mentioned
- human
Source articles
Every claim above is derived from publicly available reporting. Click through to read the original at the publisher.
- PrimarySecond hantavirus death in Tarija Department, Bolivia, linked to farming activities
vertexaisearch.cloud.google.com · 2026-06-03
The Departmental Health Service (Sedes) of Tarija, Bolivia, confirmed the second hantavirus-related death in 2026 on March 26, 2026. This fatality involved a 30-year-old male agricultural worker from Yacuiba who had incidental contact with wild rodents during fruit harvest activities. This follows the first death reported in the same area on February 13, 2026, involving a 36-year-old male. Nine suspected cases have been reported in Tarija to date in 2026, including two confirmed cases and seven ruled out. Endemic areas for hantavirus in Tarija Department include Yacuiba, Bermejo, and Padcaya
- ReferenceFour Cases of Hantavirus Infections Involving the Andes Strain Detected in Bolivia
thailandmedical.news · 2026-05-12
Health authorities in Bolivia have reported four new laboratory-confirmed hantavirus infections in the Tarija region, near the Argentina border. The cases were identified in the municipalities of Bermejo, Yacuiba, and Padcaya. Officials are concerned about increased viral circulation in neighboring Argentine provinces and the potential for human-to-human transmission of the Andes strain. Investigations are focusing on outdoor activities in rodent-infested areas like fishing camps and poorly ventilated shelters.
Reminder
This report is an aggregated summary of public information for surveillance and awareness purposes only. It is not medical advice. For symptoms, exposure, or clinical decisions, contact a qualified clinician or your local public-health authority.